Are your advanced therapy supply chains ready for this year’s 4G/LTE data management transition?
A leap forward in standardizing the regenerative medicine supply chain
We are quickly approaching the Grand Opening of our first two Global Supply Chain Centers in Houston, TX on June 14th and Morris Plains, NJ on June 16th, 2022.
Although we are about to officially open our facilities, we have already received the first doses of a cell therapy from a clinical-stage biopharmaceutical company. The therapy will be used to treat clinical trial patients with advanced B-cell lymphoma and acute myeloid leukemia at clinics across the United States. The photos below shows our team in Morris Plains receiving the material recently.
At Cryoport Systems, we are continuously striving to align with the latest science and technology advancements in our products and services, integrating the most advanced packaging, informatics, and logistics capabilities on the market today. Thus, we are pleased to share the official launch of our new Cryoport Express® Standard & Combo Cryogenic Shippers this month. The new models provide maximum protection of your valuable commodities with advanced, robust packaging and new feature enhancements. The new Cryoport Express® shippers are now available from our U.S. facilities and will soon become accessible out of our EMEA and APAC region facilities in the following months.
A Leap Forward in Standardizing the Regenerative Medicine Supply Chain – What the New ISO 21973 Guidance Means for Cell and Gene Therapy Developers
Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC
